Ivanova, E.,
Asadullina, D.,
Rakhimov, R.,
Izmailov, A.,
Izmailov, Al.,
Gilyazova, G.,
Galimov, Sh.,
Pavlov, V.,
Khusnutdinova, E.,
Gilyazova, I. (2022) renal cell carcinoma (ccRCC) patients with different clinical
response to ICIs (nivolumab) and treatment
Nazarova, Liliia Sh.,
Danilko, Ksenia V.,
Malievsky, Viktor A.,
Karimov, Denis O.,
Bakirov, Akhat B.,
Viktorova, Tatyana V. (2022) the polymorphic loci of
immune response mediator genes (TNFA rs1800629, LTA rs909253, IL1B rs16944, IL2-IL21 rs
Изменения иммунной системы в патогенезе нейрофиброматоза 1-го типа. Accordingly, the deficiency of neurofibromin impairs the differentiation and correct functioning of
immune cytokines that don't provide a proper anti-tumor
immune response, but initiate formation and growth of new
Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) , differentiation, as well as
immune response and inflammation. Recently, biological microarray technologies have